Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Incyte Corporation (INCY)

« Back to company index

INCY Chatter Timeline

Stock Ticker for INCY

Most Active Tweeters for INCY

UserTweets
@Tickeron 14
@mediasentiment 5
@sleekoptions 4
@newsfilterio 3
@DataTrials 3

Recent Tweets for INCY

newsfilterio @newsfilterio
Incyte Ranked Second Among Science Magazine’s 2020 Top Biopharma Employers $INCY https://t.co/8CQ4nRyGHo
October 30th 2020, 1:10pm
tradersreport @tradersreport
RT @Tickeron: $INCY's Aroon indicator drops into Downtrend on October 5, 2020. View odds for this and other indicators: https://t.co/NNVZyW…
October 30th 2020, 10:10am
Tickeron @Tickeron
$INCY's Aroon indicator drops into Downtrend on October 5, 2020. View odds for this and other indicators:… https://t.co/OBkaVeJk2K
October 30th 2020, 10:10am
FlashAlert_me @FlashAlert_me
$INCY [15s. delayed]: Issued Press Release on October 30, 09:00:00: Incyte Ranked Second Among Science Magazine’s 2… https://t.co/lsvkv0oILT
October 30th 2020, 9:10am
stock_titan @stock_titan
$INCY Incyte Ranked Second Among Science Magazine’s 2020 Top Biopharma Employers https://t.co/YkTWinOAJI
October 30th 2020, 9:10am
MarcJacksonLA @MarcJacksonLA
$LLY $INCY Lilly & Incyte Report Positive New Data For Baricitinib In Adult Patients With Alopecia https://t.co/OY6ySIkFWT
October 30th 2020, 8:10am
equity_newswire @equity_newswire
$INCY Pooled Results from Incyte’s TRuE-AD1 and TRuE-AD2 Atopic Dermatitis Studies of Ruxolitinib Cream Show Clinic… https://t.co/EphVygBWbD
October 30th 2020, 7:10am
sbwcws @sbwcws
Eli Lilly, Incyte announce to present new baricitinib data $LLY $INCY
October 30th 2020, 6:10am
stock_titan @stock_titan
$INCY $LLY Fall Clinical Dermatology 2020: Lilly and Incyte Showcase Positive New Data for Baricitinib in Adult Pat… https://t.co/VMyxZ45gw1
October 30th 2020, 6:10am
Miljenkoz @Miljenkoz
RT @Mazeraski: $INCY Atopic Dermatitis Studies of Ruxolitinib Cream Show Clinically Meaningful Improvements in Patient-Reported QoL Assessm…
October 29th 2020, 10:10am
Briefingcom @Briefingcom
$INCY: Incyte announced efficacy and safety results from a pooled analysis of two randomized, double-blind,... https://t.co/MzmSKPJBjp
October 29th 2020, 10:10am
Tickeron @Tickeron
$INCY's Aroon indicator drops into Downtrend on October 5, 2020. View odds for this and other indicators:… https://t.co/RyGgAbmnOn
October 29th 2020, 9:10am
MarcJacksonLA @MarcJacksonLA
$INCY Pooled Results from Incyte’s TRuE-AD1 and TRuE-AD2 Atopic Dermatitis Studies of Ruxolitinib Cream Show Clinic… https://t.co/PuIQv0K2VJ
October 29th 2020, 9:10am
Mazeraski @Mazeraski
$INCY Atopic Dermatitis Studies of Ruxolitinib Cream Show Clinically Meaningful Improvements in Patient-Reported Qo… https://t.co/I0dPvnpPoZ
October 29th 2020, 9:10am
sbwcws @sbwcws
Incyte announces pooled analysis evaluating ruxolitinib cream for dermatitis $INCY
October 29th 2020, 8:10am
the_pnw_yeti @the_pnw_yeti
$incy some relative strength
October 28th 2020, 3:10pm
Tickeron @Tickeron
$INCY's Aroon indicator drops into Downtrend on October 5, 2020. View odds for this and other indicators:… https://t.co/ksiIxOfBzN
October 28th 2020, 9:10am
TradHawk @TradHawk
RT @TradeHawk: $INCY Incyte has been awarded a five year Veterans Affairs federal supply schedule contract worth $541 million. https://t.c…
October 27th 2020, 1:10pm
DataTrials @DataTrials
$INCY Phase 1|Phase 2 Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer…NCT0206… https://t.co/S7eRxfMhsC
October 27th 2020, 11:10am
DataTrials @DataTrials
$INCY Phase 3 Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Sa… https://t.co/yLaj8fbEyr
October 27th 2020, 11:10am
DataTrials @DataTrials
$INCY Phase 2 Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Ch… https://t.co/AwvuihHSf9
October 27th 2020, 11:10am
Tickeron @Tickeron
$INCY's Aroon indicator drops into Downtrend on October 5, 2020. View odds for this and other indicators:… https://t.co/qt6kJMlO18
October 27th 2020, 9:10am
quant_data @quant_data
Incyte Received FDA Orphan Drug Designation for Retifanlimab for Treatment of Merkel Cell Carcinomaon October 26 Related Tickers: $INCY
October 27th 2020, 6:10am
s949kYPg5RyIwHm @s949kYPg5RyIwHm
RT @G_krupins: $INCY If it holds here and resumes it's move up https://t.co/7AuDB0tBQ6
October 26th 2020, 7:10pm
UnusuallyActive @UnusuallyActive
INCYTE CORPORATION $INCY UNUSUAL ACTIVITY VOLUME 2628.51% STRENGTH 3669.33%
October 26th 2020, 10:10am
newsfilterio @newsfilterio
Health Canada accepts Incyte's pemigatinib application for bile duct cancer $INCY https://t.co/e973kyac5u
October 26th 2020, 10:10am
HealthcareBeat @HealthcareBeat
Health Canada accepts Incyte's pemigatinib application for bile duct cancer $INCY https://t.co/pxwK4h7TJD
October 26th 2020, 10:10am
Tickeron @Tickeron
$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on October 21, 2020. View odds for this an… https://t.co/ZTZ8qfgLHS
October 26th 2020, 8:10am
Tickeron @Tickeron
$INCY enters a Downtrend because Momentum Indicator dropped below the 0 level on October 21, 2020. View odds for th… https://t.co/wIZQtB1Jul
October 25th 2020, 9:10am
Tickeron @Tickeron
$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on October 21, 2020. View odds for this an… https://t.co/Gb0oeYs6ip
October 24th 2020, 9:10am
optioncharts @optioncharts
$INCY Implied Volatility expiration 11/20/2020 #maxpain #options https://t.co/sH1sMMu31D https://t.co/CeAs835ZTJ
October 23rd 2020, 8:10pm
Tickeron @Tickeron
$INCY's Aroon indicator drops into Downtrend on October 5, 2020. View odds for this and other indicators:… https://t.co/3xCutU6d0q
October 23rd 2020, 11:10am
sleekoptions @sleekoptions
Peak profit for the last 6 expired option alerts for $INCY 128.57% | 136.00% | -97.08% | 6.25% | 3.02% | 19.27% |… https://t.co/4lmb1qULKC
October 22nd 2020, 7:10pm
sleekoptions @sleekoptions
$INCY - #OptionsTrading - Monthly performance of the algo based option alerts posted for INCY https://t.co/mncZfr5jCN
October 22nd 2020, 7:10pm
sleekoptions @sleekoptions
$INCY - Last six months, 22 option alerts peaked above 100% after they were triggered by the algo… https://t.co/lZ86c3fvHl
October 22nd 2020, 7:10pm
sleekoptions @sleekoptions
$INCY - View historical options performance for INCY https://t.co/fBAay8o89T https://t.co/j0Fu91dkPR
October 22nd 2020, 7:10pm
Tickeron @Tickeron
$INCY's Aroon indicator drops into Downtrend on October 5, 2020. View odds for this and other indicators:… https://t.co/dMQ8aTzOEJ
October 22nd 2020, 9:10am
OlympiaReport @OlympiaReport
Incyte Co. $INCY Receives Average Rating of “Hold” from Brokerages https://t.co/mTuAcdo7b3
October 21st 2020, 6:10pm
Tickeron @Tickeron
$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/B7w9G0uTYh
October 21st 2020, 11:10am
HealthcareBeat @HealthcareBeat
Incyte to Report Third Quarter Financial Results $INCY https://t.co/4sokUneSNW
October 21st 2020, 5:10am
newsfilterio @newsfilterio
Incyte to Report Third Quarter Financial Results $INCY https://t.co/Qn0QQA4jt5
October 21st 2020, 2:10am
ThisLincolnian @ThisLincolnian
Incyte Co. $INCY Expected to Post Earnings of $0.72 Per Share https://t.co/BMldaMVn3R
October 21st 2020, 1:10am
dailypoliticaln @dailypoliticaln
Incyte Co. $INCY Expected to Post Earnings of $0.72 Per Share https://t.co/zxQUYgY85t
October 21st 2020, 1:10am
WatchlistN @WatchlistN
$0.72 EPS Expected for Incyte Co. $INCY This Quarter https://t.co/NujyY8uekp
October 21st 2020, 1:10am
AmericanBanking @AmericanBanking
Incyte Co. $INCY Expected to Post Earnings of $0.72 Per Share https://t.co/T5xuGyaxto #stocks
October 21st 2020, 1:10am
76enz @76enz
$INCY 6%
October 20th 2020, 10:10am
Tickeron @Tickeron
$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds f… https://t.co/3qmp2F4Qzp
October 20th 2020, 8:10am
FlashAlert_me @FlashAlert_me
$INCY [15s. delayed]: Issued Press Release on October 20, 08:00:00: Incyte to Report Third Quarter Financial Results https://t.co/JMKqDXDAQQ
October 20th 2020, 8:10am
stock_titan @stock_titan
$INCY Incyte to Report Third Quarter Financial Results https://t.co/Nzf0vLFRtK
October 20th 2020, 8:10am
dakotafinancial @dakotafinancial
Reviewing Incyte $INCY & Inhibitor Therapeutics $INTI https://t.co/rqaqrZSM9t
October 20th 2020, 7:10am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.